All Type of News
The Crucial Interaction Between Brand Life Span and Market Life Cycle
Korean pharmaceutical companies need to recognize the importance of life cycle management which has been employed by multinational pharmaceutical firms, according to a local patent attorney.
In a recent patent rela...
Sliding value of won set to deal setback to pharmaceutical industry
The sudden fall of the Korean won against the U.S. dollar is posing a threat to the domestic pharmaceutical industry.
Drug makers are increasingly concerned about the won's weakness as the won’s rapid depreciation ...
KFDA to strengthen ADR reports
The Korea Food and Drug Administration says the nation’s adverse drug reaction system will be further upgraded as pharmaceutical manufacturers will be obliged to employ one or more drug safety managers from October 18...
Health insurance allowance to be possible for antibiotic Tygacil
Wyeth Korea says patients will be allowed to receive insurance reimbursement over its antibiotic Tygacil as a result of the recent pricing negotiation with the National Health Insurance Corporation.
Tigecycline is ...
Ahngook launches intensive marketing over needle-free injections system INJEX
Ahngook Pharm unveiled its plan to boost its needle-free injections system INJEX through a TV commercial to prevent diabetic patients’ anxiety created by having to "stick oneself."
Most diabetics need several injec...
New fair trade code to be approved by FTC
The Fair Trade Commission is likely to approve a new fair trade provision which was drafted by the Korea Pharmaceutical Manufacturers Association, according to a KPMA official.
The fair trade code contains more str...
Health care providers hit government’s freeze plan over medical service fee next year
Medical and pharmaceutical circles have challenged the government’s plan to freeze next year’s medical service fee due to business recession and spiraling commodity price hikes.
In a press conference on October 13,...
Recombinant DNA products total 291 for 20 years
A total of 291 products derived recombinant DNA technologies have been approved as of September 25, this year, according to data released by the Korea Food and Drug Administration.
The data showed that 13 manufactu...
Treatment guidelines for hepatocellular carcinoma to be updated
The National Cancer Center has updated treatment guidelines for patients with hepatocellular carcinoma (HCC, also called hepatoma) as part of efforts to combat cancer, according to Dr. Park Jung-won.
The guidelines...
Novartis research head visits International Vaccine Institute
Dr. Paul Herrling, head of corporate Research, Novartis Inc., visited Dr. Cecil Czerkinsky, Deputy Director-General of International Vaccine Institute (IVI) on October 9, to discuss the promotion of vaccine science fo...
